These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4439778)

  • 21. [Late results of therapy of malignant ovarian tumors].
    Kaĭstrukova DS
    Vopr Onkol; 1970; 16(9):81-5. PubMed ID: 4320989
    [No Abstract]   [Full Text] [Related]  

  • 22. Factors influencing the prognosis of ovarian cystadenocarcinomas.
    Nieminen U; Purola E
    Prog Clin Cancer; 1973; 5():237-47. PubMed ID: 4692474
    [No Abstract]   [Full Text] [Related]  

  • 23. Factors influencing ovarian cancer survival after chemotherapy.
    Webb MJ; Malkasian GD; Jorgensen EO
    Obstet Gynecol; 1974 Oct; 44(4):564-70. PubMed ID: 4413425
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ovarian adenocarcinomas: 5 year results of treatment of 157 cases irradiated at Fondation Curie (1956-1968)].
    Mathieu G; Fenton J; Rousseau J
    Bull Cancer; 1974; 61(2):161-76. PubMed ID: 4219286
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of treatment of primary ovarian carcinoma.
    Saarikoski S; Selander K; Kauppila O; Raitala R; Pystynen P
    Ann Chir Gynaecol; 1982; 71(3):156-60. PubMed ID: 7114781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical situation and therapy of ovarian carcinoma at Gynaecological Hospital of Jena University, between 1967 and 1976 (author's transl)].
    Meinhold P; Sommer H; Nöschel H; Günther M
    Zentralbl Gynakol; 1981; 103(21):1280-8. PubMed ID: 7324630
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypoglycemia associated with serous cystadenocarcinoma of the ovary.
    O'Neill RT; Mikuta JJ
    Obstet Gynecol; 1970 Feb; 35(2):287-9. PubMed ID: 4189963
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recurrence of malignant cilioepithelial ovarian cysts and their treatment].
    Vinokurov VL
    Vopr Onkol; 1972; 18(4):50-3. PubMed ID: 5028430
    [No Abstract]   [Full Text] [Related]  

  • 29. Stage and prognosis of ovarian cystadenocarcinomas.
    Nieminen U; Purola E
    Acta Obstet Gynecol Scand; 1970; 49(1):49-55. PubMed ID: 5519475
    [No Abstract]   [Full Text] [Related]  

  • 30. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of radiotherapy for state I ovarian carcinoma].
    Sheng X; Sun J; Zhou C
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic ovarian cancer.
    Smith JP; Rutledge FN
    Clin Obstet Gynecol; 1973 Jun; 16(2):286-97. PubMed ID: 4351522
    [No Abstract]   [Full Text] [Related]  

  • 33. [Postoperative Cobalt-60-teletherapy and intraperitoneal Gold-198 administration in malignant ovarian tumors].
    Reinhard B; Evers R
    Strahlentherapie; 1974 Sep; 148(3):235-41. PubMed ID: 4446039
    [No Abstract]   [Full Text] [Related]  

  • 34. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative evaluation of combined and complex methods of treatment of malignant tumors of the ovaries].
    Milian OV; Pryluts'ka NH
    Pediatr Akus Ginekol; 1975; (6):51-4. PubMed ID: 812047
    [No Abstract]   [Full Text] [Related]  

  • 36. The alterations in the activity of amylase and its salivary isoenzyme in the serum of patients with ovarian carcinoma, submitted to radiotherapy.
    Zakrzewska I; Pietryńczak M
    Rocz Akad Med Bialymst; 1997; 42(1):229-35. PubMed ID: 9581485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of diagnostic and treatment errors on survival of patients with stage I malignant tumors of the ovary (data of the Tatarstan state oncological dispensary in Kazan)].
    Chissov VI; Antoshechkina ET; Novikova EG; Moroz IP
    Sov Zdravookhr; 1991; (11):44-6. PubMed ID: 1837956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serous adenofibroma and cystadenofibroma of the ovary.
    Compton HL; Finck FM
    Obstet Gynecol; 1970 Oct; 36(4):636-45. PubMed ID: 5506473
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the role of chemotherapy adjuvant to surgery in patients with cancer of the ovary, 1st stage].
    Nechaeva ID; Vinokurov VL; Nikolaeva DV; Livshits ME; Aĭnbinder NM
    Vopr Onkol; 1983; 29(3):46-53. PubMed ID: 6836987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Postoperative radiotherapy of malignant ovarian tumors. I: Results following telecobalt grid irradiation].
    Grimm D; Heider KM; Muth CP; Salewski D; Glaser FH; Hänsgen G; Kraft M
    Radiobiol Radiother (Berl); 1982; 23(5):497-502. PubMed ID: 7156372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.